Photo

Photo detail

Visiogen’s Synchrony lens: under FDA review

Stories this photo appears in:

Abbott Expands in Eye Market with Visiogen

HEALTHCARE: $400M buyout signals good trial results for lenses

Abbott Laboratories has bought Visiogen Inc. for $400 million

Tease photo